Commenters on the US Food and Drug Administration’s (FDA) first guidance on clinical investigations and drug development programs for psychedelic drugs raised concerns about decoupling drug ...

Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of ...

Psilocybin (the active ingredient of magic mushrooms) and MDMA (the active ingredient in ecstasy) are psychedelic or hallucinogenic drugs that can change how a person sees things and feels. In 2023, ...

Last week, Eli Lilly, the world’s most valuable pharmaceutical company, agreed to buy Thiel-backed psychedelic drug developer ...

FDA finalized new guidance for testing MDMA and psilocybin in trials, days after Massachusetts advanced its own psychedelic ...

Doctors working in palliative care see promise in emerging therapies involving psychedelic drugs, but say many questions ...

The US Food and Drug Administration (FDA) offered a framework for clinical investigations and drug development programs evaluating psychedelic drugs to treat medical conditions, such as substance use ...

Eli Lilly's acquisition signals a return of psychedelic drugs for mental health. These compounds offer a new approach to rewiring neural connections in the brain. The US FDA has granted breakthrough ...

The Trump administration’s recent push for psychedelic drugs in mental healthcare may significantly shake up the industry. President Donald Trump issued an executive order in April aiming to ...

Researchers are examining the anti-depressive effects of the psychedelic drug DMT when combined with psychotherapy. Tatiana Maksimova/Getty Images According to the World Health Organization, almost 6% ...

The agreement could help accelerate research into the use of MDMA, magic mushrooms and other psychedelics to address PTSD and ...

Add Yahoo as a preferred source to see more of our stories on Google. HARTFORD - Connecticut legislators looking to expand the use of psychedelic-assisted therapy said they were encouraged by ...